SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-076018
Filing Date
2020-03-17
Accepted
2020-03-17 16:23:32
Documents
3
Period of Report
2020-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d788089d8k.htm 8-K 17829
2 EX-99 d788089dex99.htm EX-99 50919
3 GRAPHIC g788089g0317221655257.jpg GRAPHIC 2618
  Complete submission text file 0001193125-20-076018.txt   73694
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 20721291
SIC: 2834 Pharmaceutical Preparations